Skip to content

Evaluation of the Efficacy of AneuGuide in the Treatment of Intracranial Aneurysms with Stent-Assisted Coiling: A Randomized Controlled Trial

Evaluation of the Efficacy of AneuGuide in the Treatment of Intracranial Aneurysms with Stent-Assisted Coiling: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121145
Enrollment
Unknown
Registered
2026-03-26
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial aneurysm

Interventions

Experimental group (software group) :Firstly, upload the patients preoperative 3D-DSA imaging data to AneuGuide software to complete vascular 3D reconstruction, parameter extraction, and recommend the
Control group (traditional group):Completely relying on traditional experience decision-making to complete stent implantation.

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients with aneurysms who plan to receive dense mesh stent implantation treatment; 2. 18 years old and above, regardless of gender; 3. Can provide complete preoperative and postoperative clinical and imaging data, and sign informed consent forms.

Exclusion criteria

Exclusion criteria: 1. The target aneurysm is spindle shaped, traumatic, fungal, vesicular, pseudoaneurysm, dissection aneurysm, or patients with arteriovenous malformation, arteriovenous fistula, or smoky disease related aneurysms; 2. Patients with incomplete or poor image quality that cannot be processed using software; 3. Patients who are unable to complete the expected follow-up; 4. Patients who cannot collect complete clinical information; 5. Patients with other serious diseases, such as malignant tumors, severe liver and kidney dysfunction, etc; 6. Pregnant or lactating patients; 7. Expected survival period<12 months; 8. Other situations deemed unsuitable for participation in the clinical trial after evaluation by the researchers.

Design outcomes

Primary

MeasureTime frame
Occlusion of arterial aneurysm;

Secondary

MeasureTime frame
Occlusion of arterial aneurysm;Proximal Stent Anchoring Site;Metal Coverage Ratio at Aneurysm Neck;Stent Foreshortening Length;Long-Term Complications;Short-Term Complications;

Countries

China

Contacts

Public ContactFeng Fan

The First Affiliated Hospital of Zhengzhou University

286969812@qq.com+86 371 6627 8062

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026